Multiple Manufacturers

CLADRIBINE

Manufacturer:

Multiple Manufacturers

Cladribine HCPCS:

J9065

HCPCS Code Descriptor:

Injection, cladribine, per 1 mg

Category:

J Code

Cladribine NDCs:

63323-0140-10, 67457-0450-10, 42658-0010-91, 42658-0010-01, 00143-9871-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67457-0450-10, 42658-0010-01

About Cladribine:

CLADRIBINE is an Oncology drug manufactured by Mylan and administered via the Intravenous route of administration. The J Code: J9065 is aligned to the drug CLADRIBINE.

ACCESS PRICING AND MORE BY REGISTERING

J9065 Added Date:

January 1, 1995

J9065 Effective Date:

January 1, 1997

J9065 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cladribine billing and coding information.
Cladribine patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
CLADRIBINE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CLADRIBINE. Please check back in a few weeks.